Novel Coronavirus (COVID-19) Information

This is an evolving situation. Please continue to monitor our website so that you are kept abreast of any new developments.


Coming Soon

  • SCPP is working with selected partners to enable emergency therapeutic substitution options during the COVID-19 pandemic.


Latest News

Page last updated September 4, 2020.

 

Most Recent

The Saskatchewan Health Authority, in collaboration with eHealth, the Drug Plan and Extended Benefits Branch and the Ministry of Health, is recommending the addition of COVID-19-specific information when prescribing electronically using the Pharmaceutical Information Program (PIP). Please see this memo for more information.

This will allow the community pharmacy to coordinate with the patient to ensure safe dispensing of medications while limiting the risk of community exposure.

The current Health Canada section 56 exemption has been extended from September 30, 2020 to September 30, 2021.

The exemption, which outlines the terms for patients, and practitioners and pharmacists prescribing and providing controlled substances during the COVID-19 pandemic, has not changed. Also note that Health Canada can amend, terminate or extend the exemption if it deems it necessary to protect public health and safety.

Please see the Health Canada notice here.

With the curve of COVID-19 in the province flattening, the Saskatchewan Health Authority has reported that the health care system is managing with the current number of cases. Therefore, SCPP will no longer be requesting or processing applications for Emergency Practising Licences. Current emergency licences will remain valid for the 90-day period.

SCPP wishes to thank all those who applied for their willingness to answer the call for help.

Health Canada advises Canadians to help support the continued supply of medications.

The COVID-19 pandemic has resulted in significant shifts in the supply and demand of certain drugs. While supply levels may be stabilizing, supply pressures continue for certain drugs. Governments, industry, pharmacy organizations, and other health sector partners continue to work together to address supply issues, and are taking measures to conserve the supply of critical drugs. Health Canada has been monitoring the supply situation closely and will take any necessary actions, in collaboration with its partners, to help ensure the continued supply of medications for Canadians.

Patients are advised not to buy more medication than required. This will help ensure that all Canadians continue to have access to the medications they need and to prevent drug shortages.

For the full advisory, please click here.

medSask has provided guidance on pharmacists administering injections during the COVID-19 pandemic. Please click here for detailed information.

 

 

Prescribing and Drugs

The Saskatchewan Health Authority, in collaboration with eHealth, the Drug Plan and Extended Benefits Branch and the Ministry of Health, is recommending the addition of COVID-19-specific information when prescribing electronically using the Pharmaceutical Information Program (PIP). Please see this memo for more information.

This will allow the community pharmacy to coordinate with the patient to ensure safe dispensing of medications while limiting the risk of community exposure.

The current Health Canada section 56 exemption has been extended from September 30, 2020 to September 30, 2021.

The exemption, which outlines the terms for patients, and practitioners and pharmacists prescribing and providing controlled substances during the COVID-19 pandemic, has not changed. Also note that Health Canada can amend, terminate or extend the exemption if it deems it necessary to protect public health and safety.

Please see the Health Canada notice here.

Health Canada advises Canadians to help support the continued supply of medications.

The COVID-19 pandemic has resulted in significant shifts in the supply and demand of certain drugs. While supply levels may be stabilizing, supply pressures continue for certain drugs. Governments, industry, pharmacy organizations, and other health sector partners continue to work together to address supply issues, and are taking measures to conserve the supply of critical drugs. Health Canada has been monitoring the supply situation closely and will take any necessary actions, in collaboration with its partners, to help ensure the continued supply of medications for Canadians.

Patients are advised not to buy more medication than required. This will help ensure that all Canadians continue to have access to the medications they need and to prevent drug shortages.

For the full advisory, please click here.

Effective May 20th, the Saskatchewan government is lifting the supply limits on prescription medications that were introduced to guard against shortages during the COVID-19 pandemic. Though the majority of the Canadian drug supply is more stable, some drugs (e.g. salbutamol inhalers) and drug classes (e.g. sedatives and antibiotics) are in short supply. For these medications, pharmacists will use their judgement and dispense appropriate quantities. The medications supply is being actively monitored at federal and provincial levels, as the pandemic evolves.

Please see the news release here and the letter sent to pharmacy professionals here.

Health Canada has released a health product risk communication for ketamine. There is an unprecedented demand for ketamine hydrochloride injection in Canada as a result of the COVID-19 pandemic. Given the medical necessity of ketamine in Canada, Health Canada has added US-labelled Ketamine Hydrochloride 500 mg/5 mL (100 mg/mL concentration) to the List of Drugs for Exceptional Importation and Sale. Special attention is required to ensure correct patient dosing. For details, please see the safety alert from Health Canada.
medSask has provided guidance on pharmacists administering injections during the COVID-19 pandemic. Please click here for detailed information.
Due to increased demands and appropriate resource allocation during the COVID-19 pandemic, the Roy Romanow Provincial Laboratory (RRPL) will be functioning off of a limited test menu of essential services effective immediately. RRPL Comprehensive Drugs of Abuse Screen will only be performed if specific criteria are met. Those criteria have been communicated to practitioners by CPSS.

See the criteria here.
Health Canada has released a Controlled Substances Bulletin outlining the handling of post-consumer returns by pharmacists in light of the COVID-19 pandemic.
eHealth Saskatchewan has approved a provisional process for members of the College of Physicians and Surgeons of Saskatchewan (CPSS) to be able to complete a condensed application and expedited approval process for the use of the Pharmaceutical Information Program (PIP). The PIP allows prescriptions to be completed electronically, without access to an established EMR, and is a standalone online platform compatible with most internet browsers.

Please see the notice to physicians and surgeons here.

Electronic prescriptions sent to the PIP system are available to any pharmacy within Saskatchewan and all pharmacists licensed in Saskatchewan have access to the PIP. It is the patient's choice as to where to have the prescription filled. This information is to alert members that you may see an increase in prescribing in the PIP.

When requested by the patient, prescriptions on the PIP should be printed and then downloaded into the local vendor software. It is important that the popup blocker on the internet browser in the pharmacy be turned off to allow for successful printing.

The download process from the integrated PIP profile is like that of a typical prescription transfer download into the local pharmacy software. Please refer to your vendor for support if needing further assistance. Downloading an electronic prescription is recommended versus creating a new prescription locally as it prevents duplicate prescriptions from appearing in the PIP.

For further assistance regarding the PIP, contact their service desk:
Toll Free: 1-888-316-7446
Fax: 1-306-781-8480
Email: servicedesk@eHealthSask.ca.
The Canadian Association for Pharmacy Distribution Management (CAPDM) is encouraging pharmacy stakeholders to stay the course with 30-day prescription refills. With the COVID-19 pandemic, demand for medication has increased more than 200 per cent over historical norms, and adhering to the new 30-day standard will ensure every patient equal access to a limited supply. Saskatchewan pharmacies are to maintain the DPEBB restrictions until further notice.

See the letter from Dan Chiasson, president and CEO, CAPDM, to the National Association of Pharmacy Regulatory Authorities (NAPRA).
The Prescription Regulations Summary Chart has been amended during the COVID-19 pandemic, based on the Section 56(1) Exemption from Health Canada.
Health Canada is informing manufacturers, importers and compounders of medically important antimicrobials for veterinary use, that the Veterinary Antimicrobial Sales Reporting (VASR) online system will remain open to accept sales report submissions until June 30, 2020. The March 31 regulatory reporting timeframe may not be feasible due to the impact of the COVID-19 pandemic on normal business operations and personnel.

For questions about reporting requirements, email the Veterinary Drugs Directorate or visit the Veterinary Antimicrobial Sales Reporting web page.
In support of the province-wide efforts to maintain continued patient care, the SCPP Registrar is enacting Section 10(5) of Part K of the SCPP Regulatory Bylaws, effective immediately. Pharmacists are now authorized to prescribe/continue therapy as follows:
  1. quantities that exceed the limits in the bylaws;
  2. when the most previous prescription for that drug was issued by a licensed pharmacist; or
  3. when no active relationship exists between a practitioner and the patient.

This emergency exemption has been enacted in collaboration with the CPSS, SRNA, SHA, and the Ministry of Health, to support health system efforts to address the COVID-19 pandemic. It will remain in effect until September 30, 2020 or until revoked by the SCPP Registrar.

In addition to this exemption, pharmacists should review and follow the Health Canada Exemption 56 letter and guidance memo from SCPP emailed on March 23, 2020 for all drugs found in the schedules of the CDSA.

Pharmacists must document reasons for exercising these exemptions on the prescription or patient’s profile and when applicable complete a PAR.
Pharmacists are reminded to adhere to dispensing quantity limits determined by the Ministry of Health, as per the Pharmacy Information Bulletin No. 722 and the letter from the Deputy Minister of Health to Saskatchewan pharmacists.
Pharmacists must extend therapy at the same dose. Therapeutic substitutions or dosage adjustments are not permitted at this time. Patients should be encouraged to follow up with their primary practitioner when possible, but the necessity and risks must be critically assessed by the pharmacist for each individual patient. The intention is not to allow patients to circumvent follow up with their primary practitioner, but to reduce burden to the health care system and ensure continued therapy as providers may be called to care for ill and critically ill COVID-19 patients.

Pharmacists must be familiar with the OAT guidance memo emailed on March 25, 2020 when extending such therapies.

See SCPP’s Bylaw Interpretation for Exemptions to Prescribing Authority for more details. Also see, the Practice Changes for Community Pharmacy During COVID-19 Pandemic document for a summary of current exemptions and restrictions, and for examples of situations where these changes may apply.

Please stay tuned for upcoming information from DPEBB with respect to guidance on billing for Prescriptive Authority Fees.
Please review the joint message to Saskatchewan’s Doctors, Registered Nurses/Nurse Practitioners and Pharmacists regarding the use of Hydroxychloroquine (Plaquenil®) and Azithromycin for COVID-19.
Health Canada has provided all Provincial Regulatory Authorities (PRAs) with a Controlled Drugs and Substances Act (CDSA) Section 56 exemption. This exemption is in place until September 30, 2020, or the date it is replaced by another exemption or on the date it is revoked. CDSA section 56 exemption information was emailed and faxed out to all members on March 25.

Please see the OAT Emergency Contingency Plan from the College of Physicians and Surgeons of Saskatchewan.
Meetings are occurring between CPSS/SRNA and SCPP as to the direction around management of OAT patients – Please check your emails for more information.
CDSA section 56 exemption information was emailed and faxed out to all members on March 23. The section 56 exemption applies to all drugs listed in the schedules to the CDSA including but not limited to narcotics, controlled drugs, benzodiazepine and listed steroids. Please review the CDSA for all drugs listed in the schedules.
To ensure that patients maintain access to controlled substances for medical treatment during the COVID-19 pandemic, Health Canada has issued a Section 56 Exemption for all drugs covered under the Controlled Drugs and Substances Act (CDSA) to reduce regulatory barriers.

To implement these exemptions in accordance with provincial and federal requirements, the SCPP has been collaborating with Health Canada, College of Physicians and Surgeons of Saskatchewan (CPSS), Saskatchewan Registered Nurses Association (SRNA), College of Dental Surgeons of Saskatchewan (CDSS), Ministry of Health (MoH), Non-Insured Health Benefits (NIHB) and Pharmacists Association of Saskatchewan (PAS).

When is the exemption in effect:
Although enabled by Health Canada, this exemption will come into force upon official notice from the SCPP, and expires on the earliest of the following dates:
  • September 30, 2020;
  • The date that it is replaced by another exemption; or
  • The date on which it is revoked.

What does the exemption cover:
This exemption will permit:
  1. pharmacists to extend prescriptions;
  2. pharmacists to transfer prescriptions to other pharmacists;
  3. prescribers (i.e. physicians, nurse practitioners, dentists) to issue verbal orders (i.e. over the phone) to extend or refill a prescription; and
  4. pharmacy employees to deliver prescriptions of all CDSA drugs to patients’ homes or other locations where they may be (i.e. self-isolating).

Impact on Prescription Review Program (PRP)
The Ministry of Health and all of the partners in the PRP have agreed to temporarily suspended the requirement that all PRP drugs be prescribed in writing. This means that all prescriptions for any CDSA drug and those PRP Schedule I drugs can be verbally ordered by an authorized practitioner directly to a licensed pharmacist.

The SCPP is developing resources to ensure that members are aware of expectations and requirements, and to address barriers to patient care while still protecting the public of controlled substances.

We extend a huge thank you to all of our partners for working together to remove as many barriers as possible to ensure the patients of Saskatchewan can rely on the healthcare system to meet their health care needs.
To ensure a continued supply of prescription medications, the Ministry of Health has issued a directive that Saskatchewan pharmacists must limit the number and quantity of prescription drugs dispensed.
Effective immediately, Saskatchewan pharmacists may only provide:
  • A ONE MONTH supply (to a maximum of a 35 day supply) in a 28 day period for all drugs not on the Maintenance Drug Schedule;
  • A TWO MONTH supply in a 55 day period for drugs on the Two Month Drug List;
  • A 100 Day supply in a 95 day period for drugs on the 100 Day List.
This restriction applies to all prescriptions regardless whether the patient pays cash or has a private or public Drug Plan that pays for the prescription. The Ministry will be contacting private payers to notify them of this requirement.

Details from the Ministry of Health can be found in the Pharmacy Information Bulletin No. 722 and the letter from the Deputy Minister of Heath to Saskatchewan pharmacists.

Posters for pharmacies to print and communicate this change can be found here:
Document: Pharmacy Poster
Document: Protect Yourself and Others - Stop the Spread of Viruses

 

 

Pharmacy Operations

With the curve of COVID-19 in the province flattening, the Saskatchewan Health Authority has reported that the health care system is managing with the current number of cases. Therefore, SCPP will no longer be requesting or processing applications for Emergency Practising Licences. Current emergency licences will remain valid for the 90-day period.

SCPP wishes to thank all those who applied for their willingness to answer the call for help.

In order to provide medications by injection and other routes, SCPP requires that you maintain current First Aid and CPR Level C certification, complete all required training available through Continuing Professional Development for Pharmacy Professionals (CPDPP) and properly declare AMC during licence renewal.

Due to the COVID-19 pandemic and resulting physical distancing requirements, we have learned that in-person courses previously available to recertify for First Aid and CPR Level C are being postponed. As a result, some providers are extending their certificate expiry dates. The onus is on the member to determine if their First Aid and CPR Level C training is expired, and/or if any extension to the expiration date is being provided by the training agency. If your First Aid and CPR Level C certification is expired and you are unable to obtain proof that your certification has been extended, you should not provide medications by injection until you can re-certify.

SCPP is monitoring the situation regarding First Aid and CPR Level C training and will provide more information as it becomes available, but we encourage all members to check with their training provider.

In the March edition of SCOPe, SCPP reported in error that all CPR and First Aid certificates had been extended until September 30, 2020. It has since been confirmed that certificates from certain providers may be extended 90 days. Again, please check with your service provider.

Please find more information on the Registration page.

Saskatchewan health care organizations, including SCPP and the Saskatchewan Health Authority, have issued a joint statement of professional accountability that outlines principles and expectations for health care professionals as they adapt their usual practices during the COVID-19 pandemic.
April 22, 2020

As more members of health care teams are needing to self-isolate, so grows the need to find alternative means to support the health care system. On March 13, 2020, the Ministry of Health announced virtual appointment (Virtual Care) options for patients and physicians due to the COVID-19 pandemic. Effective April 21, 2020, the Virtual Care option through the Pexip software system has been expanded by the Ministry of Health to include pharmacists/pharmacies to facilitate patient consultations virtually.

Pexip is a videoconferencing software system that is compliant with HIPA and PIPEDA, and has been approved by the Ministry of Health, eHealth and the Saskatchewan Health Authority for use on computers and mobile devices. Proper knowledge of the software is required prior to using, including how to lock a room to ensure patient confidentiality.

Although pharmacy team members already use the telephone to communicate with patients and other health care providers, videoconferencing is another tool that may help to provide services. The College, through the support of medSask, has completed a comprehensive review of the listed minor ailments and has determined that a telephone consultation where deemed appropriate by the pharmacist and the use of the Pexip virtual care system would be an acceptable alternative to in-person consultations and assessments during COVID-19. Other patient care services where Pexip may be utilized would be for SMAPs, PACT and any counselling or patient monitoring activities as required.

As always, it is the discretion of the prescribing pharmacist to ensure all standards of care are met for a telephone or virtual consultation as they would be for an in-person consultation. Meaning, each patient must receive the same high standard of care whether they are receiving that care in person, over the phone or via a virtual visit.

For more information on covered services and how to register for Pexip, click here.

To access the Pexip registration form, click here.

For more information on the Pexip software system and how-to guides, click here

New Bylaw Amendments Provide Expedited Emergency Registration/Licensure

The amendments ensure expedited, no-fee, temporary emergency licensure/registration for Retired, Associate, Non-Practising members, pharmacy professionals who were previously registered/licensed with the SCPP, and pharmacy professionals (in good standing) from other Canadian jurisdictions. These professionals must have been previously licensed/registered within the last three years, be in good standing, and have no ongoing complaints investigation or disciplinary findings.

These amendments may help to address potential Pharmacist or Pharmacy Technician shortages resulting from the COVID-19 pandemic (or any other potential future emergencies). Please see the Emergency Registration and Licensure – Supplemental Policy for more information.

A pre-registration screening form is provided for further information and to express interest in obtaining this licence. Please also visit the Emergency Registration section for more information.

Amendments to Provide Interns with the Authority to Complete Advanced Method Certification (AMC) in an Emergency

At the discretion of the Registrar, this new authority will ensure an optimal number of pharmacy professionals are available to administer the flu vaccination, a potential COVID-19 vaccination, or other necessary medications by injection or other routes. This exemption for AMC is in place for 2020 graduates only as part of the emergency licensure bylaws.

The Government of Saskatchewan has created a question-and-answer document dealing with common questions about staffing and closures during the COVID-19 pandemic. Pharmacy professionals can get clear and concise guidance on situations they may face – when a pharmacy employee tests positive for COVID-19 or a pharmacy manager learns that a staff member has been exposed, for example.

These public health measures are effective April 9, 2020 but may change over time – please see the Saskatchewan government website for current information for businesses and employees.

For additional information on cleaning and infection control, see the below resources:
A new infographic was developed to direct patients on the steps to follow if they are sick or need a prescription filled. It is meant for pharmacies and physicians to post to social media, websites, stores, etc.
Pharmacy operating hours on the SCPP website are being used by health system partners and public to support emergency preparedness planning across the province. Please visit the new webpage Modifying Pharmacy Hours for procedures to change hours of operation. Further information about the SCPP policy around adjusting pharmacy operations and operating hours can be found at Emergency Preparedness – Modifications to Pharmacy Operations and Hours.
Pharmacists must continue to use Pharmacist Assessment Records (PARs) for all prescribing and maintain them as per SCPP Record Keeping Requirements. However, in collaboration with CPSS and SRNA, during the period of the COVID-19 pandemic, pharmacists will no longer be required to fax the PAR to the patient’s primary prescriber to notify them of any prescribing (e.g. minor ailments, interim supplies), with the exception of PRP medications. Patient’s primary prescribers MUST continue to be notified via fax of any extension for PRP medications.
  • SCPP has been receiving inquiries from pharmacy team members regarding the reporting of patients to the police who are not complying with the new legal requirement (both Provincial and Federal under the Quarantine Act announced March 26, 2020) to quarantine themselves whether it be after a trip outside of Canada regardless of showing symptoms or when they are experiencing symptoms of COVID-19.
Some pharmacies are unable to extend and transfer CDSA drugs due to the rules embedded in their pharmacy software. NAPRA has been working with vendors on a national level to ensure that the software system restrictions are modified to support the direction of the provinces during the COVID-19 pandemic. This includes the ability for pharmacists to do what they need to do with the CDSA drugs. If you have any questions or concerns, please reach out to your pharmacy software vendor.
Infection Control Guidelines to help pharmacies ensure that routine and advanced practices are in place to prevent transmission of communicable diseases and infections to the public and pharmacy staff. It also includes links to credible resources for extreme circumstances. Additional guidance is available on Hand Hygiene and Respiratory Hygiene and Cough Etiquette. Additional resources are posted on the SCPP website under the Resources section.
Pharmacies have been adjusting their operations and hours to continue providing pharmacy services to the public. See Emergency Preparedness – Modifications to Pharmacy Operations and Hours for an outline of the steps to follow in the event that it is necessary to adjust pharmacy operations or operating hours. It is important that pharmacy managers notify SCPP and communicate this with the public. This information is being used by health system partners to support emergency preparedness planning across the province.
In response to the evolving health risk posed by the COVID-19 pandemic, the Office of Controlled Substances (OCS) is allowing temporary measures to reduce the likelihood of spreading COVID-19 between parties when taking delivery of narcotics, controlled drugs and restricted drugs while maintaining record keeping requirements.
  • In response to the shortage of hand sanitizer, Health Canada has advised that in response to the unprecedented demand and urgent need for disinfectants and hand sanitizers during the COVID-19 pandemic, it is excluding this bulk compounding from the requirements of the Food and Drug Regulations and the Natural Health Products Regulations within the context of the practitioner-patient relationship. Retail sale to the public likely does not satisfy this requirement and would require Health Canada authorization prior to the sale. However, should pharmacies choose to compound hand sanitizer, and make it available to the public (outside of the practitioner-patient relationship), Health Canada will not prioritize the enforcement of this condition, on the condition that:
    The SCPP supports the compounding of hand sanitizer to meet patient and professional practice needs at this time with additional expectations:
    • It must be done by a licensed pharmacist or licensed pharmacy technician working with a pharmacist;
    • Professional ethics of pharmacy professionals would be maintained at all times; and
    • Once the shortage is resolved, all commercial manufacturing would cease.
  • Ongoing meetings between the SCPP and the Ministry of Health continue. The Ministry of Health is aware of the shortage of personal protective equipment for community pharmacies and the public demand for medication stockpiling which could lead to drug shortages. The Ministry is following up on these concerns. The Pharmacy Association of Saskatchewan is working with its members to gather PPE information. Updates will be provided as they become available.
  • A new Emergency Preparedness Tools document has been prepared by SCPP to inform pharmacy professionals of the tools available to help them address the risks they may be identifying in their preparations to address the COVID-19 pandemic.

    Document: Emergency Preparedness Tools (updated March 18, 2020)

    The College is working closely with the federal and provincial ministries of health, regulators and other health system partners to undertake the necessary planning to protect residents.

  • SCPP met with Health Canada and the College of Physicians and Surgeons to discuss emergency planning measures for an exemption to allow pharmacists to prescribe narcotics and controlled drugs in Saskatchewan should it be needed.

  • SCPP met with representatives from national and provincial pharmacy associations and regulators to provide updates and discuss areas for national action.

 

 

Provincial and Federal Announcements

The Saskatchewan Health Authority (SHA) released new data showing that Saskatchewan is in a significantly better position to manage COVID-19 as a result of the interventions taken to date to slow the spread of the virus.

For more details, please see the Government of Saskatchewan news release.

Health Canada and the Public Health Agency of Canada put out an urgent call for help on April 3. With the country at a critical point in the COVID-19 pandemic, and in the continuing efforts to break chains of transmission, the federal government is needing assistance in surveillance, monitoring, case reporting and contact tracking to help quickly identify cases. The direct link to apply is now active.

Anyone interested in contributing to the government’s COVID-19 response can apply online. Any questions can be directed to hc.covidvolunteer-benevolecovid.sc@canada.ca.

For the full details of the request, see the letter from Dr. Theresa Tam, chief public health officer, Tina Namiesniowski, president, Public Health Agency of Canada, and Stephen Lucas, deputy minister, Health Canada.
Health Canada and the Public Health Agency of Canada have put out an urgent call for help. With the country at a critical point in the COVID-19 pandemic, and in the continuing efforts to break chains of transmission, the federal government is needing assistance in surveillance, monitoring, case reporting and contact tracking to help quickly identify cases.

Anyone interested in contributing to the government’s COVID-19 response can apply online. Any questions can be directed to hc.covidvolunteer-benevolecovid.sc@canada.ca.

For the full details of the request, see the letter from Dr. Theresa Tam, chief public health officer, Tina Namiesniowski, president, Public Health Agency of Canada, and Stephen Lucas, deputy minister, Health Canada.
The provincial government is reminding Saskatchewan residents and businesses of the tools available during the COVID-19 pandemic. These include:
  • the regular HealthLine 811, which continues to be available for health-related enquiries.
  • the Saskatchewan Public Safety Agency Line 1-855-559-5502, which is there to answer non-health related questions, including reporting non-compliance with public health self-isolation and social-distancing orders. Businesses and residents can call 24 hours a day, as well as submit concerns online.
  • the COVID-19 website, which contains updated reliable information and a self-assessment tool.
  • the Business Response Team, which can be reached at 1-844-800-8688 for business-related questions and support.
  • a donation-specific email – procurement@gov.sk.ca – available for businesses and organizations that wish to offer supplies and other solutions for health-care workers.
The Saskatchewan Health Authority is expanding capacity to meet demand for future phases of the COVID-19 pandemic. Please review Saskatchewan Health Authority's communication.
Health Canada has released an advisory about steps it is taking to improve access to disinfectants, hand sanitizers, personal protective equipment and swabs. To help limit the spread of COVID-19 it has taken interim measures to allow products that do not meet the French/English language requirements for labelling. See Health Canada Advisory for more information.
On March 18, the Government of Saskatchewan declared a provincial State of Emergency. This gives the government broad powers to address the COVID-19 pandemic. This includes measures like the ability to direct that property or equipment be deployed to address the COVID-19 pandemic. Effective immediately the government has directed that pharmacies must have processes to maintain a one to two metre of separation between people.

As part of Saskatchewan’s health care system, the government has assured the public that Saskatchewan pharmacies are open to help residents during the COVID-10 pandemic.

To assist with you your business continuity plans, the SCPP will continue to provide links to credible resources such as the CPHA Infection Control Poster available in fillable PDF format to use in your pharmacy.

The SCPP is also exploring virtual care options to provide pharmacy services by telephone, secure video link and other technology, and following up on availability of medical supplies and personal protective equipment for community pharmacies.
Saskatchewan confirms its first presumptive case of COVID-19. See the Saskatchewan Ministry of Health article for more information: Saskatchewan Confirms Presumptive Case of COVID-19
The World Health Organization (WHO) declares COVID-19 as a pandemic. See the World Health Organization (WHO) article for more information: WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020
With the introduction of the novel coronavirus 2019 in Canada, the Ministry of Health is undertaking the necessary planning to protect residents from transmission, support the healthcare system in the event of confirmed cases, and provide stakeholders and the public with accurate information about the risk and provincial readiness.

Partners, including the Public Health Agency of Canada, and Saskatchewan Ministry of Health and the Saskatchewan Health Authority, are leading this work.

Resources

 

 

SASKATCHEWAN COLLEGE OF PHARMACY PROFESSIONALS

Powered by in1touch